ZA96548B - Method for treating drug addiction - Google Patents

Method for treating drug addiction

Info

Publication number
ZA96548B
ZA96548B ZA96548A ZA96548A ZA96548B ZA 96548 B ZA96548 B ZA 96548B ZA 96548 A ZA96548 A ZA 96548A ZA 96548 A ZA96548 A ZA 96548A ZA 96548 B ZA96548 B ZA 96548B
Authority
ZA
South Africa
Prior art keywords
drug addiction
treating drug
treating
addiction
drug
Prior art date
Application number
ZA96548A
Other languages
English (en)
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of ZA96548B publication Critical patent/ZA96548B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA96548A 1995-02-01 1996-01-24 Method for treating drug addiction ZA96548B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies

Publications (1)

Publication Number Publication Date
ZA96548B true ZA96548B (en) 1996-08-14

Family

ID=23505399

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96548A ZA96548B (en) 1995-02-01 1996-01-24 Method for treating drug addiction

Country Status (12)

Country Link
US (3) US6469044B1 (enExample)
EP (1) EP0724878B1 (enExample)
KR (1) KR100425045B1 (enExample)
AR (1) AR003921A1 (enExample)
DE (1) DE69512760T2 (enExample)
ES (1) ES2139842T3 (enExample)
IL (1) IL114296A (enExample)
LT (1) LT4339B (enExample)
RO (1) RO116771B1 (enExample)
RU (1) RU2182001C2 (enExample)
UA (1) UA63878C2 (enExample)
ZA (1) ZA96548B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469044B1 (en) * 1995-02-01 2002-10-22 Neurim Pharmaceuticals (1991) Ltd. Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
IL130171A (en) * 1999-05-27 2004-06-01 Neurim Pharma 1991 Melatonin for use in the prevention and treatment of tardive dyskinesia, pharmaceutical formulations comprising it and its use for the manufacture of medicaments
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
US6998112B2 (en) * 2003-03-18 2006-02-14 Arthur Zuckerman Sleep inducing toothpaste made with natural herbs and a natural hormone
RU2361583C2 (ru) * 2003-10-03 2009-07-20 Вейлен Н.В. Применение соединений, способных повышать уровень igf-1 в сыворотке крови, при приготовлении терапевтической композиции для лечения стадий различных заболеваний, ассоциированных со снижением уровня igf-1 в сыворотке людей и животных
MXPA06009377A (es) * 2004-02-20 2007-03-07 Lifescape Biosciences Inc Composiciones y metodos para regulacion del sueno.
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
JP6025755B2 (ja) 2011-02-11 2016-11-16 ズィーエックス ファーマ，エルエルシー 多粒子ｌ−メントール製剤及びその関連する方法
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
RU2488388C1 (ru) 2012-05-24 2013-07-27 Ооо "Валента Интеллект" Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств
UA107653U (uk) 2012-10-01 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
BR112015006499A2 (pt) 2013-04-23 2017-07-04 Zx Pharma Llc composição de óleo de horlelã-pimenta de liberação controlada microparticulada com revestimento entérico e métodos relacionados
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
DK3337462T3 (da) 2016-10-31 2020-10-12 Neurim Pharma 1991 Melatonin-minitabletter og fremgangsmåde til fremstilling heraf
JP2025533153A (ja) 2022-10-14 2025-10-03 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 持続放出性メラトニン組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600723A (en) 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
AU601736B2 (en) 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
US4800087A (en) 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US5242941A (en) 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
DE69229490T2 (de) * 1991-05-09 2000-02-17 Neurim Pharmaceuticals (1991) Ltd., Tel Aviv Melatonin enthaltende Arzneimittel
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
US5449683A (en) 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
US6469044B1 (en) * 1995-02-01 2002-10-22 Neurim Pharmaceuticals (1991) Ltd. Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies

Also Published As

Publication number Publication date
US20020156121A1 (en) 2002-10-24
EP0724878A2 (en) 1996-08-07
RO116771B1 (ro) 2001-06-29
LT4339B (lt) 1998-05-25
US20030040539A1 (en) 2003-02-27
RU2182001C2 (ru) 2002-05-10
DE69512760D1 (de) 1999-11-18
IL114296A0 (en) 1995-10-31
HK1001218A1 (en) 1998-06-05
KR100425045B1 (ko) 2004-09-01
ES2139842T3 (es) 2000-02-16
EP0724878A3 (enExample) 1996-08-21
DE69512760T2 (de) 2000-05-31
US6833383B2 (en) 2004-12-21
US6469044B1 (en) 2002-10-22
AR003921A1 (es) 1998-09-30
IL114296A (en) 1999-10-28
LT97135A (en) 1997-12-29
KR19980701640A (ko) 1998-06-25
EP0724878B1 (en) 1999-10-13
UA63878C2 (en) 2004-02-16

Similar Documents

Publication Publication Date Title
IL122718A0 (en) Methods for treating diabetes
SG52832A1 (en) Method for treating substance abuse withdrawal
GB2299821B (en) Process for treating oil-bearing formation
PL315020A1 (en) Capsulation process
GB2297562B (en) Knitting method
IL125031A0 (en) Method for treating depression
GB9518442D0 (en) Method
AU8402598A (en) Method for treating nicotine addiction
IL117970A0 (en) Method for treating nicotine withdrawal
GB9515868D0 (en) Therapeutic method
IL124786A0 (en) Method for treating pain
GB9502225D0 (en) Method
GB9510727D0 (en) Method
AP9701121A0 (en) Method for prearing streptogramines
GB9513129D0 (en) Treatment method
GB9513130D0 (en) Treatment method
GB9511594D0 (en) Treatment method
GB9606615D0 (en) Method for treating alcohol addiction
GB9520585D0 (en) Therapeutic method
AP9801221A0 (en) A process for treating tobacco
GR950200228U (en) Method for treating carob pods
GB9517851D0 (en) New therapeutic method
GB9505179D0 (en) Process for fluoroaromatics
HUT76309A (en) Method for decontamination
GB9514713D0 (en) Method